This is the authors' abstract. We don't add key points for this paper.
Background Anti-GDF-15 antibody currently undergoes validation in clinical trials as a novel therapy for several solid cancers. Macrophages are key regulators of the tumor immune microenvironment and act as a source and target of GDF-15. GDF-15 effect on macrophage programming is an open question. Methods RNA sequencing (RNA seq) followed by RT-qPCR was used to identify the transcriptome induced by GDF-15 in primary human monocyte-derived macrophages. Western blotting was used to examine signaling pathways. Bioinformatic analysis of GDF15/IL17RB/IL8 pathway was performed using TCGA datasets. Tumor samples from 62 patients with primary clear cell renal cell carcinoma (ccRCC) who underwent nephrectomy between 2006 and 2011 were analyzed by RT-qPCR, immunohistochemistry and confocal microscopy. Results RNA seq showed that rGDF-15 treatment altered 210 genes in M0 and 372 in M2 (IL-4-driven) macrophages, with enrichment in angiogenesis and immune regulation pathways. GDF-15-target gene IL17RB was significantly upregulated and functionally responsive to its ligand IL-17E. Despite enhanced NF-κB p65 phosphorylation after stimulation with IL-17E, an IL17RB ligand, GDF-15 reduced IL-6 and IL-8 production, indicating an anti-inflammatory effect. Mechanistically, GDF-15 enhanced STAT6 and induced Smad2/3 phosphorylation, and both responses were abrogated by pharmacological inhibition of TGFBR1. TCGA analyses of ccRCC samples revealed that higher IL17RB expression was associated with favorable overall and disease-specific survival (DSS), whereas higher IL8 expression was associated with unfavorable survival outcomes. In an internal cohort of 62 patients with ccRCC, GDF15 correlated with IL17RB expression and remained independently associated with IL17RB after adjustment for clinicopathological variables. Confocal microscopy confirmed that IL17RB is almost exclusively expressed in CD68 + macrophages within ccRCC tumors. Although neither GDF15 nor IL17RB was associated with DSS in the internal cohort, IL8 was associated with worse DSS in an exploratory multivariable analysis. The favorable association of IL17RB with survival in TCGA, together with its macrophage localization, supports the existence of a potentially protective GDF-15-associated state in ccRCC. Conclusions These findings suggest that broad GDF-15 blockade may have unfavorable consequences in selected ccRCC contexts and support tumor-specific evaluation of GDF-15-targeted therapies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Silva-Bermúdez et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: